Cargando…
Cancer Immunotherapies Targeting Tumor-Associated Regulatory T Cells
Tumor-associated regulatory T cells (Tregs) are important effectors in the tumor microenvironment (TME), acting as accomplices in the promotion of tumor progression. Currently, the importance of removing the immunosuppressive activity in the TME has received its due attention, and Tregs have been fo...
Autores principales: | Ge, Xiaoxu, Zhao, Yamei, Chen, Chao, Wang, Jian, Sun, Lifeng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6917600/ https://www.ncbi.nlm.nih.gov/pubmed/31997881 http://dx.doi.org/10.2147/OTT.S231052 |
Ejemplares similares
-
The prognostic value of tumor-infiltrating lymphocytes in colorectal cancer differs by anatomical subsite: a systematic review and meta-analysis
por: Zhao, Yamei, et al.
Publicado: (2019) -
An Efficient Prognostic Immune Scoring System For Colorectal Cancer Patients With Peritoneal Metastasis
por: Zhao, Yamei, et al.
Publicado: (2021) -
Molecular Alterations in Metastatic Ovarian Cancer From Gastrointestinal Cancer
por: Chen, Chao, et al.
Publicado: (2020) -
Targeting regulatory T cells for immunotherapy in melanoma
por: Huang, Lili, et al.
Publicado: (2021) -
Targeting the right regulatory T-cell population for tumor immunotherapy
por: Weiss, Vivian L., et al.
Publicado: (2012)